PETNET allies with GlaxoSmithKline

Article

CTI Molecular Imaging subsidiary PETNET Solutions has struck a deal to provide PET isotopes to a GlaxoSmithKline research site. The isotopes will be used for preclinical research. PETNET will have the option, at GSK's discretion, to license diagnostic

CTI Molecular Imaging subsidiary PETNET Solutions has struck a deal to provide PET isotopes to a GlaxoSmithKline research site. The isotopes will be used for preclinical research. PETNET will have the option, at GSK's discretion, to license diagnostic PET probes developed by GSK. The partnership is in line with PETNET's strategy to develop new proprietary probes that will augment its existing R&D pipeline.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Current Insights on Interoperability, Enterprise Imaging and AI Integration in Radiology
A Closer Look at the Mammo Enhance Heart Program: An Interview with Arthy Saravanan, MD
Current Perspectives on Prostate Cancer and Emerging Theranostic Agents, Part 1
© 2025 MJH Life Sciences

All rights reserved.